Pages that link to "Q69014954"

The following pages link to Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate (Q69014954):

Displaying 31 items.

• Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence (Q24595863) (← links)
• The development of acamprosate as a treatment against alcohol relapse (Q26862199) (← links)
• The clinical pharmacology of acamprosate. (Q27687874) (← links)
• Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification (Q28240310) (← links)
• Clinical pharmacokinetics of acamprosate (Q28290502) (← links)
• Acamprosate (Q29299720) (← links)
• Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. (Q33616639) (← links)
• Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats (Q33828177) (← links)
• Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate (Q33835680) (← links)
• Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. (Q34115849) (← links)
• Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats (Q34320180) (← links)
• Neurobiology of relapse to alcohol in rats (Q34792823) (← links)
• Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal (Q35589974) (← links)
• Pharmacology of acamprosate: an overview. (Q35597129) (← links)
• Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats (Q35887957) (← links)
• Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence (Q36133836) (← links)
• Development of pharmacotherapies for drug addiction: a Rosetta stone approach (Q37383571) (← links)
• Operant behavior and alcohol levels in blood and brain of alcohol-dependent rats (Q37463676) (← links)
• Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities (Q38926517) (← links)
• Acamprosate in alcohol dependence: how does it work? (Q40426314) (← links)
• Acamprosate in Alcohol Dependence: Implications of a Unique Mechanism of Action (Q42730448) (← links)
• Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption (Q43593969) (← links)
• Effects of Naltrexone Alone and In Combination With Acamprosate on the Alcohol Deprivation Effect in Rats (Q44407113) (← links)
• Acamprosate and its efficacy in treating alcohol dependent adolescents (Q44455169) (← links)
• Acamprosate attenuates cocaine- and cue-induced reinstatement of cocaine-seeking behavior in rats. (Q48630840) (← links)
• Acamprosate decreases the hypermotility during repeated ethanol withdrawal. (Q48175565) (← links)
• Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats (Q48386138) (← links)
• Effects of Acamprosate on Cognition in a Treatment Study of Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence (Q51001917) (← links)
• Comparison of acamprosate and placebo in long-term treatment of alcohol dependence (Q71177254) (← links)
• Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons (Q73689679) (← links)
• Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future (Q92189687) (← links)